HANGZHOU TIGERMED CO. H 1 Capital Reinvestment Ratio
HANGZHOU TIGERMED CO. H 1 capital reinvestment ratio. HANGZHOU TIGERMED CO. H 1 (5HZ1) has a Capital Reinvestment Ratio of 0.19x as of December 2025, meaning it reinvests 0% of its operating cash flow (€1.12 Billion) in capital expenditures (€214.37 Million). Check cash flow reinvestment rate of HANGZHOU TIGERMED CO. H 1 to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of HANGZHOU TIGERMED CO. H 1 (2021–2025)
Capital reinvestment ratio of HANGZHOU TIGERMED CO. H 1 from 2021 to 2025. This chart tracks HANGZHOU TIGERMED CO. H 1's Capital Reinvestment Ratio across 5 annual periods. Also explore HANGZHOU TIGERMED CO. H 1 annual equity growth to track the company's year-over-year net asset growth rate.
HANGZHOU TIGERMED CO. H 1 Capital Reinvestment Ratio by Year (2021–2025)
HANGZHOU TIGERMED CO. H 1 capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see 5HZ1 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | €1.12 Billion | €214.37 Million | ▼ -41.0% |
| 2024 | 0.33x | €1.10 Billion | €356.55 Million | ▲ +19.2% |
| 2023 | 0.27x | €1.15 Billion | €313.76 Million | ▼ -17.5% |
| 2022 | 0.33x | €1.36 Billion | €448.60 Million | ▲ +27.6% |
| 2021 | 0.26x | €1.42 Billion | €368.62 Million | — |